FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.
What happened
FDA conducted a Foreign Remote Regulatory Assessment of the seafood processing facility on April 9-13, 2023, after a consumer complaint of histamine poisoning from yellowfin tuna loins led to a voluntary recall. FDA found serious violations of the seafood HACCP rule: the HACCP plan lacked a critical control point for histamine formation during transport from the harvest vessel, monitoring was inadequate, and corrective actions did not ensure the cause was fixed. FDA reviewed the company's August 16, 2023 response but found the HACCP concerns continued.
What FDA found
The HACCP plan did not list a critical control point to control histamine (scombrotoxin) formation while fresh tuna was transported from the harvest vessel to the processing facility.
21 CFR 123.6(a) and (c)(2)The HACCP plan's monitoring procedures and frequencies at critical control points were not adequate to control histamine formation; FDA said continuous temperature recording and a daily visual check of the recorded data should be used.
21 CFR 123.6(c)(4)The corrective action plan did not ensure that the cause of a deviation was corrected at the critical control points.
21 CFR 123.7(b)
What FDA wants
FDA asks the company to respond in writing within 15 working days with specific corrective steps and documentation, including a revised HACCP plan and five consecutive days of completed monitoring records for five production date codes. If corrections cannot be completed in 15 days, the company must explain the delay and when it will finish.
Who should pay attention
- brands and importers that buy frozen tuna from this processor
- seafood distributors using foreign suppliers
- quality teams managing histamine controls and supplier HACCP verification
This is a summary. Read the original letter on fda.gov.